Anne-Marie Hanekamp

Equibles does not estimate personal net worth.

Get an email with a short summary when BioNTech SE publishes a filing, an earnings call transcript or a press release.

About Anne-Marie Hanekamp

Anne-Marie Hanekamp has spoken on 1 earnings call across 1 company, most recently for BioNTech SE on November 3, 2026. BioNTech SE is classified in the Biotechnology industry within the Healthcare sector.

Anne-Marie Hanekamp on recent calls

“I will just also add that in line with our strategy, what we shared before on Permitamik, we believe that this next-gen bispecific will be the backbone in different settings and cancer types, and that we're moving this ahead with our partner BMS in chemo combinations, but also, to your point, in combination with other…”

Other, 2026 Q3 Earnings Call · November 3, 2026